组合弹性图在心力衰竭患者的预后影响
Takahiro Sakamoto1,2, Seita Yamasaki1, Taiji Okada1
1Division of Cardiology, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo 693-8501, Shimane, Japan.
Journal of clinical medicine
|January 28, 2026
概括
组合弹性学有效预测心力衰竭 (HF) 患者的心脏事件. 这种非侵入性方法,使用剪切波速度和肝纤维化指数,为管理肝炎和肝脏拥堵提供预后价值.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 医疗成像医学成像
背景情况:
- 弹性图形评估组织刚性的非侵入性,与剪切波和菌株成像有用的肝纤维化 (LF).
- 剪波成像反映了纤维化和肝脏拥堵;应变成像反映了纤维化进展,受拥堵的影响较小.
- 以前的研究表明组合弹性图在心力衰竭 (HF) 中具有临床用途,但其预后意义尚不清楚.
研究的目的:
- 为了前性地评估结合性弹性素学在心力衰竭 (HF) 患者的预后影响.
主要方法:
- 包括七十七名HF患者 (平均年龄:79岁).
- 测量了剪切波速度 (Vs) 和肝纤维化指数 (LF).
- 计算V/LF指数 (V/L) 作为预后指标.
主要成果:
- 在随访期间 (中位数为716天),发生了17起心脏事件 (死亡或HF住院).
- 预测心脏事件的V/L切断值为1.2,AUC为0.80,灵敏度为0.82,特异性为0.68.
- 高V/L (≥1.2) 与显著更高的HF住院率相关 (日志等级测试,p < 0.001).
结论:
- 组合弹性图显示出HF患者的预后效用.
- 这种非侵入性方法可能有助于评估肝脏拥堵.
- V/L指数作为HF管理的新预后工具.
相关概念视频
Heart Failure II: Pathophysiology
872
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
872
Pathophysiology of Heart Failure
3.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
Heart Failure I: Introduction
847
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
847
Heart Failure VI: Adjunct Therapies
314
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
314
Heart Failure Drugs: Diuretics
948
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
948
Heart Failure V: Medical Management
272
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
272


